Shrenik Gelecekteki Büyüme

Future kriter kontrolleri 0/6

Şu anda Shrenik için büyüme ve gelir tahmini yapmak üzere yeterli analist kapsamımız yok.

Anahtar bilgiler

n/a

Kazanç büyüme oranı

n/a

EPS büyüme oranı

Trade Distributors kazanç büyümesi	6.8%
Gelir büyüme oranı	n/a
Gelecekteki özkaynak getirisi	n/a
Analist kapsamı	None
Son güncelleme	n/a

Gelecekteki son büyüme güncellemeleri

Güncelleme yok

Recent updates

Should You Be Worried About Shrenik Limited's (NSE:SHRENIK) 1.5% Return On Equity?

Mar 07

Here's Why Shrenik (NSE:SHRENIK) Is Weighed Down By Its Debt Load

Feb 15

Estimating The Intrinsic Value Of Shrenik Limited (NSE:SHRENIK)

Jan 28

Is Shrenik (NSE:SHRENIK) Likely To Turn Things Around?

Jan 11

Bu bölümde, yatırımcıların şirketin kâr elde etme kabiliyetini anlamalarına yardımcı olmak için genellikle profesyonel analistlerin fikir birliği tahminlerine dayanan gelir ve kazanç büyüme tahminlerini sunuyoruz. Ancak Shrenik yeterli geçmiş veri sağlamadığından ve analist tahmini olmadığından, gelecekteki kazançları geçmiş verileri ekstrapole ederek veya analist tahminlerini kullanarak güvenilir bir şekilde hesaplanamaz.

SimplyWall St tarafından kapsanan şirketlerin %97'si geçmiş finansal verilere sahip olduğu için bu oldukça nadir bir durumdur.

Kazanç ve Gelir Büyüme Tahminleri

NSEI:SHRENIK - Analistlerin gelecek tahminleri ve geçmiş finansal verileri (INR Millions )
Tarih	Gelir	Kazançlar	Serbest Nakit Akışı	Faaliyetlerden Nakit	Avg. Analist Sayısı
9/30/2024	245	-2,351	N/A	N/A	N/A
6/30/2024	288	-616	N/A	N/A	N/A
3/31/2024	342	-2,355	208	208	N/A
12/31/2023	402	-34	N/A	N/A	N/A
9/30/2023	406	-28	N/A	N/A	N/A
6/30/2023	452	-481	N/A	N/A	N/A
3/31/2023	486	2	468	469	N/A
12/31/2022	482	-11	N/A	N/A	N/A
9/30/2022	461	-28	-94	-94	N/A
6/30/2022	417	-101	N/A	N/A	N/A
3/31/2022	638	-144	-77	-77	N/A
12/31/2021	1,356	-116	N/A	N/A	N/A
9/30/2021	1,721	-117	98	98	N/A
6/30/2021	3,390	-31	N/A	N/A	N/A
3/31/2021	3,637	-15	269	269	N/A
12/31/2020	4,198	11	N/A	N/A	N/A
9/30/2020	5,759	53	231	235	N/A
6/30/2020	6,250	61	N/A	N/A	N/A
3/31/2020	7,956	113	85	104	N/A
12/31/2019	8,771	140	N/A	N/A	N/A
9/30/2019	8,956	134	-369	-301	N/A
6/30/2019	8,683	120	N/A	N/A	N/A
3/31/2019	8,368	111	-247	-181	N/A
12/31/2018	7,743	94	N/A	N/A	N/A
9/30/2018	7,131	93	N/A	N/A	N/A
6/30/2018	6,532	86	N/A	N/A	N/A
3/31/2018	5,932	79	N/A	-469	N/A
3/31/2017	4,277	42	N/A	-131	N/A
3/31/2016	3,292	29	N/A	-75	N/A
3/31/2015	2,657	10	N/A	60	N/A
3/31/2014	2,131	10	N/A	-73	N/A

Analist Gelecek Büyüme Tahminleri

Kazançlar ve Tasarruf Oranları: SHRENIK 'un tahmini kazanç büyümesinin tasarruf oranının ( 6.7% ) üzerinde olup olmadığını belirlemek için yeterli veri yok.

Kazançlar ve Piyasa: SHRENIK 'un kazançlarının Indian pazarından daha hızlı büyümesinin öngörülüp öngörülmediğini belirlemek için yeterli veri yok

Yüksek Büyüme Kazançları: SHRENIK şirketinin kazançlarının önümüzdeki 3 yıl içerisinde önemli ölçüde artıp artmayacağını belirlemek için yeterli veri bulunmuyor.

Gelir ve Pazar: SHRENIK şirketinin gelirinin Indian pazarından daha hızlı büyüyeceğinin tahmin edilip edilmediğini belirlemek için yeterli veri yok.

Yüksek Büyüme Geliri: SHRENIK şirketinin gelirinin yıllık 20% oranından daha hızlı artacağının tahmin edilip edilmediğini belirlemek için yeterli veri yok.

Hisse Başına Kazanç Büyüme Tahminleri

Gelecekteki Özkaynak Getirisi

Gelecekteki ROE: SHRENIK 'un Özsermaye Getirisi'nin 3 yıl içinde yüksek olmasının öngörülüp öngörülmediğini belirlemek için yeterli veri yok

Shrenik Gelecekteki Büyüme

Future kriter kontrolleri 0/6

Anahtar bilgiler

Gelecekteki son büyüme güncellemeleri

Recent updates

Chairman & MD recently sold ₹3.6m worth of stock

Chairman & MD recently sold ₹3.4m worth of stock

Chairman & MD recently sold ₹1.9m worth of stock

Chairman & MD recently sold ₹3.1m worth of stock

Second quarter 2025 earnings released

New major risk - Negative shareholders equity

Chairman & MD recently sold ₹1.8m worth of stock

Chairman & MD recently sold ₹244k worth of stock

Chairman & MD recently sold ₹769k worth of stock

Shrenik Limited, Annual General Meeting, Sep 30, 2024

Chairman & MD recently sold ₹313k worth of stock

First quarter 2025 earnings released

Chairman & MD recently sold ₹181k worth of stock

Chairman & MD recently sold ₹728k worth of stock

Insufficient new directors

Shrenik Limited Appoints Nirav Harshvadan Zaveri as Independent Director

Full year 2024 earnings released

Chairman & MD recently sold ₹6.5m worth of stock

Chairman & MD recently sold ₹295k worth of stock

Chairman & MD recently sold ₹1.1m worth of stock

Chairman & MD recently sold ₹542k worth of stock

Chairman & MD recently sold ₹207k worth of stock

Chairman & MD recently sold ₹543k worth of stock

Chairman & MD recently sold ₹544k worth of stock

Third quarter 2024 earnings released

Chairman & MD recently sold ₹626k worth of stock

Chairman & MD recently sold ₹370k worth of stock

Chairman & MD recently sold ₹1.0m worth of stock

Chairman & MD recently sold ₹1.7m worth of stock

Chairman & MD recently sold ₹973k worth of stock

Is Shrenik (NSE:SHRENIK) A Risky Investment?

Chairman & MD recently sold ₹935k worth of stock

First quarter 2024 earnings released: ₹0.77 loss per share (vs ₹0.01 profit in 1Q 2023)

Chairman & MD recently sold ₹1.3m worth of stock

Chairman & MD recently sold ₹1.2m worth of stock

Full year 2023 earnings released: EPS: ₹0.004 (vs ₹0.23 loss in FY 2022)

Chairman & MD recently sold ₹1.1m worth of stock

Is Shrenik (NSE:SHRENIK) Using Debt Sensibly?

Chairman & MD recently sold ₹108k worth of stock

Chairman & MD recently sold ₹2.4m worth of stock

Chairman & MD recently sold ₹2.5m worth of stock

Chairman & MD recently sold ₹1.6m worth of stock

Third quarter 2023 earnings released: EPS: ₹0.01 (vs ₹0.02 loss in 3Q 2022)

Is Shrenik (NSE:SHRENIK) A Risky Investment?

Chairman & MD recently sold ₹425k worth of stock

Chairman & MD recently sold ₹481k worth of stock

Chairman & MD recently sold ₹140k worth of stock

Chairman & MD recently sold ₹805k worth of stock

Second quarter 2023 earnings released: EPS: ₹0.03 (vs ₹0.09 loss in 2Q 2022)

Chairman & MD recently sold ₹519k worth of stock

Is Shrenik (NSE:SHRENIK) A Risky Investment?

Shrenik Limited, Annual General Meeting, Sep 29, 2022

Chairman & MD recently sold ₹774k worth of stock

Chairman & MD recently sold ₹957k worth of stock

Chairman & MD recently sold ₹1.2m worth of stock

First quarter 2023 earnings released: EPS: ₹0.01 (vs ₹0.06 loss in 1Q 2022)

Chairman & MD recently sold ₹190k worth of stock

Chairman & MD recently sold ₹335k worth of stock

Chairman & MD recently sold ₹233k worth of stock

Be Wary Of Shrenik (NSE:SHRENIK) And Its Returns On Capital

Full year 2022 earnings released: ₹0.23 loss per share (vs ₹0.024 loss in FY 2021)

Investors Could Be Concerned With Shrenik's (NSE:SHRENIK) Returns On Capital

Third quarter 2022 earnings: Revenues and EPS in line with analyst expectations

Chairman & MD recently sold ₹12m worth of stock

Shrenik (NSE:SHRENIK) Use Of Debt Could Be Considered Risky

Whole Time Director recently sold ₹9.9m worth of stock

Investors Could Be Concerned With Shrenik's (NSE:SHRENIK) Returns On Capital

Second quarter 2022 earnings released

Chairman & MD recently sold ₹3.6m worth of stock

Insider recently sold ₹782k worth of stock

Board Member recently sold ₹8.5m worth of stock

Does Shrenik (NSE:SHRENIK) Have A Healthy Balance Sheet?

First quarter 2022 earnings released: ₹0.06 loss per share (vs ₹0.03 loss in 1Q 2021)

Independent Director Manali Shah has left the company

Insider recently sold ₹744k worth of stock